UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between depression and anxiety disorders clinical trials and research opportunities
Affects ~1 in 6 UK adults. Treatment-resistant depression is a major trial focus, with psychedelics, ketamine, and neuromodulation generating significant research activity.
The most common mental health condition in the UK. Trials focus on CBT delivery methods, pharmacotherapy, and digital therapeutic approaches.
Depression trials increasingly explore novel mechanisms (psychedelics, neuromodulation). Anxiety trials focus more on delivery format and combination therapies.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
